Companion Diagnostics Market Research Reports & Industry Analysis
The companion diagnostics market is one of the fastest growing segments of the IVD and clinical lab services markets. In the United States, over half of all FDA approvals for companion diagnostics have occurred since 2010. The closely associated pharmacodiagnostics IVD market is expected to grow annually by over 20%. The wild success of reference laboratories in the companion diagnostics market even prompted the unprecedented expansion of FDA oversight over laboratory developed tests (LDTs).
Companion diagnostics are increasingly integral to the approval of some new pharmaceuticals, illustrating which individuals are most likely to benefit from the drug. With the approval of CDx-assisted therapies, new high-growth markets are opened for lab tests and IVD products.
Companion diagnostics (CDx) include in vivo or medical imaging procedures and in vitro diagnostic (IVD) lab tests used to determine the efficacy of a particular therapy, most commonly pharmaceutical. Genome research in recent decades has illuminated and detailed the role genetics play in drug metabolism and disease etiology. Drugs can now be paired with IVD and medical imaging tests for prescription decisions and therapeutic monitoring. In vitro companion diagnostics are largely molecular assays, though additional formats include immunohistochemistry (IHC) and immunoassays, and are offered as test kits, analyte specific reagents, and laboratory developed tests (LDTs) or a lab testing service.
The majority of companion diagnostics are pharmacodiagnostic lab tests used to assess an individual’s response to drug therapy. Pharmacodiagnostics represents a major front in a healthcare system-wide push towards personalized medicine. Pharmacodiagnostic tests can be used to determine patient response to clopidogrel anticoagulant drugs, appropriate drug dosage, and the prescription of oncology drugs based on genetic markers.
Stay abreast of fast-paced and promising companion diagnostics markets with MarketResearch.com’s collection of market research studies. We offer a wide selection of studies treating companion diagnostic regulation, regional and disease-specific market development, product and test pipelines, and companion diagnostic product market tracking.
Companion Diagnostics Industry Research & Market Reports
-
Global Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Considered 2019-2029 Base Year 2023 Forecast Period 2024-2029 Page Count 152 Units Referenced US $ Segments/Key Topics By Technology, By Workflow, By Application, By End User Regions Covered North America (The US, Canada, Mexico), Europe ... Read More
-
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
... is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustained growth in drug-diagnostic combinations seeking regulatory ... Read More
-
In Vitro Diagnostic (IVD) Trends and Market Update: December 2024
... to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health ... Read More
-
The World Market for Cancer Diagnostics, 2024-2029
... Information’s The World Market for Cancer Diagnostics, 2024-2029 delivers an authoritative and comprehensive analysis of the global cancer in vitro diagnostics (IVD) market, including industry-defining trends, market sizing, and growth opportunities. This report offers an ... Read More
-
Asia-Pacific Companion Diagnostics Market: Focus on Application, End User, Technology, and Country - Analysis and Forecast, 2023-2033
... and is expected to reach $2,849.7 million by 2033, growing at a CAGR of 14.53% between 2023 and 2033. The Asia-Pacific (APAC) companion diagnostics market is growing as a result of increased approvals for companion ... Read More
-
Europe Companion Diagnostics Market: Focus on Application, End User, Technology, and Country - Analysis and Forecast, 2023-2033
... and is expected to reach $3,562.1 million by 2033, growing at a CAGR of 12.30% between 2023 and 2033. Advances in biomedical imaging, a rise in companion diagnostics product approvals, and the rising prevalence of ... Read More
-
Companion Diagnostic Technologies Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 12.4% during 2025-2034. This report on global companion diagnostic technologies market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032
... Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2024-2032 The global companion diagnostics market size reached US$ 6.7 Billion in 2023. ... Read More
-
Theranostics: Global Markets
... competitive landscape, market trends and market dynamics such as drivers, restraints and opportunities. The report provides historic, current and projected market value. By product type, the market is segmented into theranostics equipment and theranostics agents. ... Read More
-
Companion Diagnostics Market Market By Technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Gene Sequencing, and Others), By Indication (Cancer, Neurological Diseases, Infectious Diseases, and Others), By End-user (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), Regional Outlook– Global Forecast up to 2030
... Contract Research Organizations, and Others), Regional Outlook– Global Forecast up to 2030 Therapeutic drugs are used in conjunction with a medical instrument known as a companion diagnostic to evaluate how well they function and how ... Read More
-
Oncology Companion Diagnostics Global Market Report 2024
... In Situ Hybridization (FISH); Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS)4) By End User: Hospital; Pathology Or Diagnostic Laboratory; Academic Medical CenterCovering: F. Hoffmann-La Roche AG; Bayer Diagnostic; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher ... Read More
-
Companion Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 21.82% during the forecast period (2024-2029). Terahertz technology is an emerging and growing field with the potential for developing applications ranging from passenger scanning at an airport ... Read More
-
Biodesix Inc (BDSX) - Product Pipeline Analysis, 2024 Update
... trial support and testing. It markets its products under the brand names including GeneStrat, VeriStrat, Nodify Lung and IQLung. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for ... Read More
-
Companion Diagnostics
... at a CAGR of 2.1% over the analysis period 2023-2030. Companion Diagnostics Assay kits & Reagents, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$9.7 Billion ... Read More
-
Companion Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030
... (Pcr), Others), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Others), By End-User (Hospitals, Diagnostic Labs, Others), by geography, is expected to grow at a noteworthy CAGR till 2030 owing to the increase in the ... Read More
-
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... Companion Diagnostics (CDx) market size was valued at USD 9869.6 million in 2023 and is forecast to a readjusted size of USD 24800 million by 2030 with a CAGR of 14.1% during review period. The ... Read More
-
Global Companion Diagnostics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Companion Diagnostics Market by Technology (Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing), Indication (Cancer, Cardiovascular Diseases, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 7.30 billion in 2024, at a CAGR 10.65% to reach USD 13.49 billion by 2030. Companion diagnostics are specialized tests designed to help healthcare professionals determine whether a particular medical ... Read More
-
Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Global Forecast 2024-2030
... expected to reach USD 75.70 billion in 2024, at a CAGR 11.22% to reach USD 143.43 billion by 2030. Precision medicine refers to the strategy of tailoring disease prevention and treatment solutions by considering the ... Read More
-
2024 Global Forecast for Companion Diagnostics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global market is expected to increase from ... Read More
-
2024 Global Forecast for Pharmacogenomics Technology/Theranostics/Companion Diagnostics (Cdx) Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Companion Diagnostics: Technologies and Markets
... analysis of the drivers, opportunities, restraints, and challenges in the market. The report details the companion diagnostics market share based on product and service, type of test, technology, and application. The market’s products and services ... Read More
-
Companion Diagnostics Market Size, Trends, Analysis, and Outlook By Products and Services (Assays, Kits & Reagents, Software & Services), By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In Situ Hybridization, Immunohistochemistry, Others), By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), by Country, Segment, and Companies, 2024-2032
... Disorders, Cardiovascular Diseases, Infectious Diseases, Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Others), by Country, Segment, and Companies, 2024-2032 The global Companion Diagnostics market size is poised to register 10.9% ... Read More
-
Fluorescent In Situ Hybridization Market Size, Trends, Analysis, and Outlook By Probe (Locus Specific Probes, Alphoid/Centromere Repeat Probes, Whole Chromosome Probes), By Application (Cancer Research, Genetic Diseases, Others), By End-User (Research Organizations, Clinical Organizations, Biotechnology Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032
... Companies, Companion Diagnostics, Others), by Country, Segment, and Companies, 2024-2032 The global Fluorescent In Situ Hybridization market size is poised to register 8.2% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Companion Animal Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Immunodiagnostics, Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, Others), By Application (Clinical Pathology, Bacteriology, Virology, Parasitology, Others), By Animal (Dog, Cat, Horse, Others), By End-User (Diagnostics Laboratories, Veterinary Clinics, Hospitals, Research Institute, Others), by Country, Segment, and Companies, 2024-2032
... (Diagnostics Laboratories, Veterinary Clinics, Hospitals, Research Institute, Others), by Country, Segment, and Companies, 2024-2032 The global Companion Animal Diagnostics market size is poised to register 7.7% growth from 2024 to 2032, presenting significant growth prospects ... Read More
Research Assistance
